Results 221 to 230 of about 160,619 (316)
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
Retention versus replacement or removal of catheters for people with confirmed or suspected intravascular catheter-related infections. [PDF]
Izawa J +3 more
europepmc +1 more source
Aim Fluorescence‐guided surgery enhances intraoperative visualization of anatomical structures. Nizaracianine is a near‐infrared fluorescent agent that is exclusively renally cleared in animal models. It enables real‐time ureteral imaging and identification, potentially reduces risk of injury and facilitates assessment before surgical closure.
Lisanne K. A. Neijenhuis +5 more
wiley +1 more source
Risk Factor Prediction Model for Catheter-Associated Bloodstream Infections (CABSIs) in Midline and Central Venous Catheters: A Cohort Follow-Up Study. [PDF]
Lafuente-Cabrero E +9 more
europepmc +1 more source
Abstract Background Postoperative opioids, intended for short‐term analgesia, contribute to new persistent opioid use in 1%–7% of patients, adversely affecting outcomes. Oxycodone may carry higher risk than morphine, though long‐term data are limited.
Eward J. Melis +5 more
wiley +1 more source
Dislodgement Rates of Tunneled Femoral Peripherally Inserted Central Catheters in Pediatric Oncology Patients. [PDF]
Yang Y +6 more
europepmc +1 more source
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
A critical use of peripherally inserted central catheters in the intensive care unit. [PDF]
Veiga VC, Soares PHR, Kalil A, Póvoa P.
europepmc +1 more source
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller +9 more
wiley +1 more source
Acute inferior STEMI in a unique setting: case report on anomalous circumflex and multivessel coronary artery disease. [PDF]
Salah Eldin Taha H, Mamdouh Shaker M.
europepmc +1 more source

